Company Filing History:
Years Active: 2012
Title: Eva Binder - Innovator in Pharmaceutical Composition
Introduction
Eva Binder is a prominent legal representative and inventor based in Vienna, Austria. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Alzheimer's disease and arteriosclerosis. Her innovative work has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Eva Binder holds a patent for the "Use of oxicam compounds." This invention relates to the use of lornoxicam or its analogues, which inhibit cyclo-oxygenase 1 and cyclo-oxygenase 2 (COX 1 and COX 2). These compounds are designed to not penetrate the blood-brain barrier under physiological conditions and reduce the prostaglandin E2-induced induction of the amyloid-precursor-protein (APP). This patent aims to produce a pharmaceutical composition for the treatment or prevention of Alzheimer's disease or arteriosclerosis. She has 1 patent to her name.
Career Highlights
Eva Binder has established herself as a key figure in the pharmaceutical industry. Her work at Dritte Patentportfolio Beteiligungsgesellschaft Mbh & Co. Kg has allowed her to focus on innovative solutions that address pressing medical challenges. Her expertise in legal representation complements her inventive capabilities, making her a valuable asset in her field.
Collaborations
Eva collaborates with various professionals in her field, including her coworker Dieter Binder. Their combined efforts contribute to the advancement of pharmaceutical innovations and the successful implementation of their patented technologies.
Conclusion
Eva Binder is a remarkable inventor whose work in pharmaceutical compositions has the potential to significantly impact the treatment of Alzheimer's disease and arteriosclerosis. Her dedication to innovation and collaboration continues to drive advancements in the medical field.